Vida Ventures Makes Progress Towards $600 Million Fund Goal

July 17, 2019

Life science focused Vida Ventures is advancing on its goal of raising $600 million for its second VC fund. According to a recent filing, Vida has raised more than $536 million of its goal.

The company has secured commitments from 109 investors for the fund. It is unclear from the filing if $600 million is a hard cap on the fund.

Vida's website lists 12 companies in its portfolio. This includes: Allogene, Praxis and Peloton Therapeutics. It was recently announced that Peloton will be acquired by Merck for an upfront payment of $1.05 billion. Peloton shareholders will be elligible to receive an additional $1.15 billion contingent upon successful achievement of future regulatory and sales milestones.

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.